Company profile
Arxx Therapeutics company profile
Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis
Business identity
- Website
- https://arxxtx.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $0+
- Founded
- 2018-01-01
Headquarters
- Headquarters
- Oslo, Oslo, Norway
- Postal code
- Oslo
- Country code
- NO
- Continent
- Europe